254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections

BACKGROUND: AmpC beta-lactamase producing organisms are traditionally treated with carbapenem or fluoroquinolone antibiotics. Recent studies, however, describe similar clinical outcomes in patients that receive cefepime or piperacillin/tazobactam. We sought to assess outcomes in patients with bloods...

Descripción completa

Detalles Bibliográficos
Autores principales: Staicu, Mary L, Baumeister, Tyler, Laguio-Vila, Maryrose R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778046/
http://dx.doi.org/10.1093/ofid/ofaa439.298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778046/
http://dx.doi.org/10.1093/ofid/ofaa439.298

Ejemplares similares